IDNA — IDNA Genomics Public Cashflow Statement
0.000.00%
Last trade - 00:00- €76.19m
- €77.83m
- €0.49m
Annual cashflow statement for IDNA Genomics Public, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 7 W | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 0.25 | -0.365 | -1.34 |
| Depreciation | |||
| Non-Cash Items | 0.046 | 0.095 | 0.045 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -0.479 | 1.05 | 1.05 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Accounts Payable | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -0.143 | 0.922 | -0.011 |
| Capital Expenditures | -0.16 | -0.146 | -0.716 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | 0.048 | — | — |
| Sale of Business | |||
| Cash from Investing Activities | -0.112 | -0.146 | -0.716 |
| Financing Cash Flow Items | — | -0.095 | -0.131 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 0.214 | -0.801 | 0.682 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -0.041 | -0.024 | -0.045 |